ARFONAD Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Arfonad, and when can generic versions of Arfonad launch?
Arfonad is a drug marketed by Roche and is included in one NDA.
The generic ingredient in ARFONAD is trimethaphan camsylate. Additional details are available on the trimethaphan camsylate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ARFONAD?
- What are the global sales for ARFONAD?
- What is Average Wholesale Price for ARFONAD?
Summary for ARFONAD
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| Patent Applications: | 538 |
| DailyMed Link: | ARFONAD at DailyMed |
US Patents and Regulatory Information for ARFONAD
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roche | ARFONAD | trimethaphan camsylate | INJECTABLE;INJECTION | 008983-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
